Lenvima
Visual Identity for EISAI Lenvimia® cancer drug EASL DIGITAL LIVER CANCER SUMMIT 2021 “TIME TO REFLECT” (Agency 90TEN)
The brief was to communicate that Clinical trials are much less complex than the clinical treatment reality, and that when the patient has to face treatment the recovered data from trials doesn’t necessary apply to their case and treatment course gets more complicated.
The brief was to communicate that Clinical trials are much less complex than the clinical treatment reality, and that when the patient has to face treatment the recovered data from trials doesn’t necessary apply to their case and treatment course gets more complicated.
This needed to get done using stock images, no suffering or negative messages and no cancer or illnesses wording. The result is a strong image that communicates exactly what the message was, the journey of the trial data into a real-life patient.
The EASL digital summit was very successful with more than 760 articles distributed in more than 48 countries reaching a total of 5000 billion readers.
Agency: 90Ten
